(Q46506824)

English

The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation

scientific article published on 2 July 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18594792

The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation (English)

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18594792

atherosclerosis

1 reference

based on heuristic

inferred from title

author name string

A C Calkin

1

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18594792

S Giunti

2

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18594792

K J Sheehy

3

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18594792

C Chew

4

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18594792

V Boolell

5

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18594792

Y S Rajaram

6

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18594792

M E Cooper

7

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18594792

K A Jandeleit-Dahm

8

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18594792

publication date

2 July 2008

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18594792

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18594792

51

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18594792

9

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18594792

1731-1740

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18594792

https://scigraph.springernature.com/pub.10.1007/s00125-008-1060-6

0 references

Why does diabetes increase atherosclerosis? I don't know!

1 reference

https://api.crossref.org/works/10.1007%2FS00125-008-1060-6

21 January 2018

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

1 reference

https://api.crossref.org/works/10.1007%2FS00125-008-1060-6

21 January 2018

Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization

1 reference

https://api.crossref.org/works/10.1007%2FS00125-008-1060-6

21 January 2018

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

1 reference

https://api.crossref.org/works/10.1007%2FS00125-008-1060-6

21 January 2018

Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-008-1060-6

21 January 2018

Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs

1 reference

https://api.crossref.org/works/10.1007%2FS00125-008-1060-6

21 January 2018

Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall

1 reference

https://api.crossref.org/works/10.1007%2FS00125-008-1060-6

21 January 2018

Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT).

1 reference

https://api.crossref.org/works/10.1007%2FS00125-008-1060-6

21 January 2018

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of combined treatment with an angiotensin II receptor antagonist and an HMG-CoA reductase inhibitor on atherosclerosis in genetically hyperlipidemic rabbits

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelial Protection, AT1 Blockade and Cholesterol-Dependent Oxidative Stress: The EPAS Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of the human tumor necrosis factor-α promoter by angiotensin II and lipopolysaccharide in cardiac fibroblasts: different cis-acting promoter sequences and transcriptional factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Macrovascular complications in relation to hyperinsulinaemia in non-insulin-dependent diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glycohemoglobin measured by automated affinity HPLC correlates with both short-term and long-term antecedent glycemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase and Isoprenylation Inhibitors Induce Apoptosis of Vascular Smooth Muscle Cells in Culture

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blockade of angiotensin II receptors reduces the expression of receptors for advanced glycation end products in human endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mevalonate-dependent inhibition of transendothelial migration and chemotaxis of human peripheral blood neutrophils by pravastatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A noninvasive computerized tail-cuff system for measuring blood pressure in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined effects of HMG-CoA-reductase inhibition and renin-angiotensin system blockade on experimental atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitory effect of candesartan and rosuvastatin on CD40 and MMPs expression in apo-E knockout mice: novel insights into the role of RAS and dyslipidemia in atherogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NF-kappaB activation is essential for angiotensin II-dependent proliferation and migration of vascular smooth muscle cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular outcomes among participants with diabetes in the recent large statin trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Valsartan therapy has additive anti-oxidative effect to that of fluvastatin therapy against low-density lipoprotein oxidation: studies in hypercholesterolemic and hypertensive patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of diabetes is retarded by ACE inhibition in hypertensive patients--a subanalysis of the Captopril Prevention Project (CAPPP).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of fluvastatin on growth of porcine and human vascular smooth muscle cells in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of cultured vascular smooth muscle cell migration by simvastatin (MK-733)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18594792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-008-1060-6

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18594792

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18594792

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46506824&oldid=2115279667"